IRIS
MOAVERO, ROMINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.577
AS - Asia 3.269
EU - Europa 2.061
SA - Sud America 470
AF - Africa 58
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 6
Totale 25.467
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.496
SG - Singapore 1.769
IT - Italia 440
CN - Cina 414
BR - Brasile 378
RU - Federazione Russa 329
HK - Hong Kong 299
VN - Vietnam 280
IE - Irlanda 241
DE - Germania 236
UA - Ucraina 224
FR - Francia 157
GB - Regno Unito 142
KR - Corea 133
JP - Giappone 99
FI - Finlandia 85
NL - Olanda 69
IN - India 55
TW - Taiwan 47
PL - Polonia 45
AR - Argentina 40
CA - Canada 34
MX - Messico 27
AU - Australia 26
BD - Bangladesh 24
SE - Svezia 24
AT - Austria 23
ID - Indonesia 22
IQ - Iraq 21
TR - Turchia 20
ZA - Sudafrica 16
EC - Ecuador 13
ES - Italia 12
CO - Colombia 11
MA - Marocco 11
SA - Arabia Saudita 10
UZ - Uzbekistan 10
MY - Malesia 9
PH - Filippine 9
CZ - Repubblica Ceca 8
VE - Venezuela 8
DZ - Algeria 7
EG - Egitto 7
PK - Pakistan 7
TH - Thailandia 7
AE - Emirati Arabi Uniti 6
KE - Kenya 6
PE - Perù 6
CR - Costa Rica 5
EU - Europa 5
PY - Paraguay 5
RO - Romania 5
BG - Bulgaria 4
KZ - Kazakistan 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BO - Bolivia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
JO - Giordania 3
LB - Libano 3
BE - Belgio 2
BH - Bahrain 2
CL - Cile 2
ET - Etiopia 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
LK - Sri Lanka 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
SM - San Marino 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KM - Comore 1
KN - Saint Kitts e Nevis 1
LT - Lituania 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
Totale 25.465
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.442
Wilmington 4.708
Houston 3.813
Singapore 889
Fairfield 743
Ashburn 414
Ann Arbor 413
San Jose 370
Chandler 316
Seattle 305
Hong Kong 294
Cambridge 232
Dublin 230
Jacksonville 187
Medford 178
Beijing 146
Santa Clara 146
Rome 126
The Dalles 103
Los Angeles 101
New York 100
Dearborn 97
Council Bluffs 92
Ho Chi Minh City 89
Lawrence 88
Dallas 81
Tokyo 79
Hanoi 74
Buffalo 68
Lauterbourg 65
Chicago 62
Moscow 58
Taipei 42
Menlo Park 36
Norwalk 35
San Diego 35
Kraków 33
São Paulo 33
Munich 29
North Bergen 29
London 25
Milan 25
Nuremberg 25
Salt Lake City 25
Haiphong 20
Redondo Beach 20
Jakarta 18
Lappeenranta 18
Helsinki 17
Mülheim 16
Orem 16
Chennai 14
Del Norte 14
Redwood City 14
Rio de Janeiro 14
Amsterdam 13
Frankfurt am Main 13
Atlanta 12
Elk Grove Village 12
Melbourne 12
Phoenix 12
Warsaw 12
Boardman 11
Montreal 11
Seoul 11
Stockholm 11
Vienna 11
Lancaster 10
Mexico City 10
Villa Adelina 10
Curitiba 9
Da Nang 9
Denver 9
Johannesburg 9
Catania 8
Kuala Lumpur 8
Manchester 8
Miami 8
Mumbai 8
New Delhi 8
Paris 8
Redmond 8
Ribeirão Preto 8
Shanghai 8
Sterling 8
Sydney 8
Tashkent 8
University Center 8
Bethesda 7
Boston 7
Brno 7
Brooklyn 7
Falls Church 7
Hefei 7
Hải Dương 7
Modena 7
Mountain View 7
Nanjing 7
Saint Petersburg 7
Tampa 7
Totale 21.065
Salva come PNG Salva come JPEG
Nome #
Current role of perampanel in pediatric epilepsy 529
Neurological and neuropsychiatric aspects of tuberous sclerosis complex. 497
Cognitive development in females with PCDH19 gene-related epilepsy 463
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions 463
mTOR Inhibitors in Tuberous Sclerosis Complex. 449
Peri-ictal water drinking: a rare automatic behaviour in temporal lobe epilepsy 440
Current role of melatonin in pediatric neurology: Clinical recommendations 438
Genotype/Phenotype Correlations in Tuberous Sclerosis Complex. 433
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders. 431
Mammalian Target of Rapamycin Inhibitors and Life-Threatening Conditions in Tuberous Sclerosis Complex. 426
Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis 423
Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy 423
Reduction in retinal nerve fiber layer thickness in tuberous sclerosis complex. 421
Long-term follow-up in children with benign convulsions associated with gastroenteritis 417
Is mTOR inhibition a systemic treatment for tuberous sclerosis? 415
Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC 414
Syndromic autism: Causes and pathogenetic pathways 412
The neurobiology of attention deficit/hyperactivity disorder. 412
Clinical Reasoning: A girl presenting with stiffness episodes during sleep, café-au-lait spots, and flecked retina 405
Abnormal parieto-motor connectivity in Tuberous Sclerosis Complex 404
Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex 401
Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor 398
Current role of rufinamide in the treatment of childhood epilepsy: literature review and treatment guidelines 395
Headache and attention deficit and hyperactivity disorder in children: common condition with complex relation and disabling consequences 395
The Challenge of Pharmacotherapy in Children and Adolescents with Epilepsy-ADHD Comorbidity 392
Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation 389
Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment. 386
Combined targeted treatment in early onset epilepsy associated with tuberous sclerosis 383
Risk and Protective Environmental Factors Associated with Autism Spectrum Disorder: Evidence-Based Principles and Recommendations 381
Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: The first Italian prospective study 380
White matter disruption is associated with persistent seizures in tuberous sclerosis complex 380
Everolimus Alleviates Obstructive Hydrocephalus due to Subependymal Giant Cell Astrocytomas 379
Tubers, epileptogenic foci, and epileptogenic networks in tuberous sclerosis. 378
Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. 376
The neurobiological basis of ADHD. 374
The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective 374
Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges. 373
Ketogenic diet in early myoclonic encephalopathy due to non ketotic hyperglycinemia 373
Attention deficit hyperactivity disorder in children with epilepsy. 367
MTOR inhibitors as a new therapeutic option for epilepsy 365
Paediatric use of melatonin (Author reply to D. J. Kennaway). 361
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex 355
Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations. 354
Can we change the course of epilepsy in tuberous sclerosis complex? 344
Syndrome of Transient Headache and Neurologic Deficits With Cerebrospinal Fluid Lymphocitosis Should Be Considered in Children Presenting With Acute Confusional State 341
New perspectives in Autism spectrum disorder associated with tuberous sclerosis 329
Vagus nerve stimulation for refractory epilepsy in tuberous sclerosis. 301
Pharmacotherapy of idiopathic generalized epilepsies 296
Neuroimaging findings of Sturge-Weber Syndrome in a child with Tuberous Sclerosis 292
Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations 288
Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy 286
Recent advances in neurobiology of Tuberous Sclerosis Complex 270
A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) 246
Autism spectrum disorder and 3p24.3p23 triplication: a case report 218
A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: A Delphi consensus report 194
mTOR dysregulation and tuberous sclerosis-related epilepsy 183
Everolimus for Retinal Astrocytic Hamartomas in Tuberous Sclerosis Complex 177
Early Clinical Predictors of Autism Spectrum Disorder in Infants with Tuberous Sclerosis Complex: Results from the EPISTOP Study 174
Cyclic vomiting syndrome and benign paroxysmal torticollis are associated with a high risk of developing primary headache: A longitudinal study 152
Clinical Features of Pediatric Idiopathic Intracranial Hypertension and Applicability of New ICHD-3 Criteria 151
Prophylactic treatment of pediatric migraine: Is there anything new in the last decade? 145
Features of primary chronic headache in children and adolescents and validity of ICHD 3 criteria 145
Immediate and prolonged-release melatonin in children with neurodevelopmental disabilities. Author reply to Prof. Zisapel 140
Is autism driven by epilepsy in infants with Tuberous Sclerosis Complex? 130
Tolerability of palmitoylethanolamide in a pediatric population suffering from migraine: a pilot study 121
Restless legs syndrome and growing pains in childhood: understanding the link 117
Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial 102
Case Report: Migralepsy: The Two-Faced Janus of Neurology 99
Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination 98
Benign Intracranial Hypertension Due to Hypoparathyroidism: A Case Report 98
Anxiety, Depression, and Body Weight in Children and Adolescents With Migraine 96
Autism and epilepsy in patients with Tuberous Sclerosis Complex 94
Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review 93
Questionnaire-based assessment of sleep disorders in an adult population of Tuberous Sclerosis Complex 88
Sleep Disorders in Pediatric Migraine: A Questionnaire-Based Study 87
Primary Headaches and Sleep Disorders: Review of Literature about Comorbidity in Children and Adolescents 85
Sleep-related painful erection: the first case in a child 84
Sleep disturbances and behavioral symptoms in pediatric Sotos syndrome 82
Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience 80
I stay at home with headache. A survey to investigate how the lockdown for COVID-19 impacted on headache in Italian children 80
Long-Term Effects of COVID-19 Pandemic on Migraine in Adolescents. A Retrospective Analysis of the Population Attending the Headache Center in Different Phases of the Pandemic 79
Diagnosis of pediatric anti-NMDAR encephalitis at the onset: A clinical challenge 79
Restless sleep disorder in a sample of children and adolescents with autism spectrum disorder: preliminary results from a case series 78
A Case Report of Pediatric Patient with Tuberous Sclerosis and Radiologically Isolated Syndrome 78
Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes 75
Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study 73
Screen exposure and sleep: How the COVID-19 pandemic influenced children and adolescents - A questionnaire-based study 70
High Intellectual Potential and High Functioning Autism: Clinical and Neurophysiological Features in a Pediatric Sample 70
Interictal Cognitive Performance in Children and Adolescents With Primary Headache: A Narrative Review 68
Case report: A pediatric case of Bickerstaff brainstem encephalitis after COVID-19 vaccination and Mycoplasma pneumoniae infection: Looking for the culprit 68
Prenatal mTOR Inhibitors in Tuberous Sclerosis Complex: Current Insights and Future Directions 66
Event-Related Potentials in ADHD Associated With Tuberous Sclerosis Complex: A Possible Biomarker of Symptoms Severity? 62
How to Assess the Headache—Sleep Disorders Comorbidity in Children and Adolescents 60
Migraine and Its Equivalents: What Do They Share? A Narrative Review on Common Pathophysiological Patterns 59
Sleep Disorders in a Sample of Patients with Pediatric-Onset Multiple Sclerosis: Focus on Restless Legs Syndrome 58
Clinical Variability of Pediatric MERS: Insights from a Retrospective Observational Study 58
miRNAs and isomiRs: Serum-Based Biomarkers for the Development of Intellectual Disability and Autism Spectrum Disorder in Tuberous Sclerosis Complex 58
Surgery for drug-resistant tuberous sclerosis complex-associated epilepsy: who, when, and what 57
Medication Overuse Withdrawal in Children and Adolescents Does Not Always Improve Headache: A Cross-Sectional Study 56
Neuropsychological Sequelae, Quality of Life and Adaptive Behavior in Children and Adolescents with Anti-NMDAR Encephalitis: A Narrative Review 54
Totale 25.056
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.606
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021175 0 0 0 0 0 0 0 0 0 0 142 33
2021/2022729 33 53 28 9 18 62 25 21 159 54 52 215
2022/2023848 96 89 17 81 79 232 87 35 67 3 39 23
2023/2024407 42 9 21 3 28 97 8 3 2 12 96 86
2024/20252.821 57 662 353 153 80 178 140 101 140 452 254 251
2025/20263.875 298 193 482 270 496 141 566 558 492 330 49 0
Totale 25.828